RSS

Mologic

A clinical trial has been started to evaluate and validate a urine-based point of care (POC) diagnostic from Mologic, aimed at helping cystic fibrosis (CF) patients monitor and manage their condition at home. Read more

Technology

Mologic (developer of personalised diagnostics) has signed agreements with two medical companies — Medisur and Peripal — for the distribution of a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD) Read more

Technology

International nonprofit organization, PATH, and UK-based test developer, Mologic, have entered into an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax or relapsing malaria. Read more

Technology